---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-008904"
form_type: "8-K"
ticker: "ENSC"
cik: "0001716947"
company_name: "Ensysce Biosciences, Inc."
filed_at: "2023-03-24T23:59:59+00:00"
generated_at: "2026-06-17T16:51:52.573223+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Ensysce shareholders approve reverse stock split at ratio of 1:5 to 1:12

## Summary
- Reverse split proposal approved with 2,836,326,468 For, 280,656,829 Against, 19,762,315 Abstain.
- Board authorized to set exact ratio between 1-for-5 and 1-for-12 at its discretion.
- Second proposal lacked quorum and was not voted; adjournment proposal not submitted.
- Special meeting held March 23, 2023; only reverse split proposal was submitted to vote.

## SEC filing metadata
- accession: 0001493152-23-008904
- form_type: 8-K
- ticker: ENSC
- cik: 0001716947
- company_name: Ensysce Biosciences, Inc.
- filed_at: 2023-03-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1716947/000149315223008904/0001493152-23-008904-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716947/000149315223008904/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-008904
- JSON: https://secwatch.observer/filing/0001493152-23-008904.json
- Plain text: https://secwatch.observer/filing/0001493152-23-008904.txt

## Key facts
- Shareholder Votes
  Ensysce Biosciences, Inc. shareholders approved Approve an amendment to the Certificate of Incorporation to authorize a Reverse Stock Split at a ratio of not less than one-for-five and not more than one-for-twelve at the 2023-03-23 meeting.
  - Proposal: reverse split
  - Outcome: passed
  - Meeting: 2023-03-23
  source text: Proposal to approve an amendment to the Company’s Certificate of Incorporation to authorize the Company’s Board of Directors to combine outstanding shares of the Company’s common stock into a lesser number of outstanding shares, a “Reverse Stock Split,” by a ratio of not less than one-for-five and not more than one-for-twelve, with the exact ratio to be set within this range by the Board in its sole discretion, in the form attached as Annex A to this Proxy Statement (the “Reverse Split Proposal”): For Against Abstentions 2,836,326,468 280,656,829 19,762,315
  evidence_url: https://www.sec.gov/Archives/edgar/data/1716947/000149315223008904/0001493152-23-008904-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.